-
Prospects and Challenges of Chitosan-Based Drug Carriers for Anticancer Agents’ Delivery Against Lung Cancer: A Review
24 Oct 2025 14:10 GMT
… lung cancer into non-small cell lung cancer (NSCLC) and small cell lung cancer … of lung cancer.
Current treatment modalities for lung cancer include … CPT-NPs inhibited lung tumor growth by … N, Roberts CJ. Cetuximab-conjugated chitosan-pectinate (modified …
-
<![CDATA[VS-7375 Shows Early Promise Against KRAS G12 Mutant Solid Tumors]]>
02 Nov 2025 03:47 GMT
… with advanced non–small cell lung cancer (NSCLC) in China … IASLC 2025 World Conference on Lung Cancer, which reported an objective … and in combination with cetuximab (Erbitux) in adult patients with … evaluating VS-7375 with cetuximab just months after trial …
-
NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth
31 Oct 2025 07:00 GMT
… head and neck cancer and lung cancer
Financing establishes financial foundation toward … neck cancer (NANORAY-312) and lung cancer (CONVERGE) within this timeframe, and … radiation therapy, with or without cetuximab, for the treatment of patients …
-
Lung Cancer Drugs Shows Promise for Treatment-Resistant Melanoma
11 Jun 2025 19:07 GMT
… and lung cancers. The researchers tested two drugs from this class, Erbitux (cetuximab) and …
-
Investigational MK-1084 Demonstrates Antitumor Activity in Phase I Trial for Colorectal and Non-Small Cell Lung Cancers
31 May 2025 01:07 GMT
… CRC) and non-small cell lung cancer (NSCLC). Across both patient … and in combination with cetuximab with or without chemotherapy … with non-small cell lung cancer. Based on early evidence … metastatic non-small cell lung cancer.”
Upcoming KANDLELIT-012 trial …
-
Merck Announces MK-1084, an Investigational KRAS G12C Inhibitor, Shows Antitumor Activity in Phase 1 Trial of Patients With Advanced Colorectal Cancer and Non-Small Cell Lung Cancer Whose Tumors Harbor KRAS G12C Mutations
30 May 2025 12:21 GMT
… CRC) and non-small cell lung cancer (NSCLC). In patients with … as in combination with cetuximab with or without chemotherapy … test.
Non-Small Cell Lung Cancer
KEYTRUDA, in combination with … metastatic nonsquamous non-small cell lung cancer (NSCLC), with no …
-
Phase 1/2 Trial Investigating ATR-04 for EGFRi-Related Rashes in Lung Cancer
28 May 2025 22:23 GMT
… patients with non-small cell lung cancer, colorectal cancer and others, … , such as non-small cell lung cancer, colorectal cancer, pancreatic cancer, …
EGFR inhibitors — including drugs like Erbitux (cetuximab), Vectibix (panitumumab), Tarceva (erlotinib) …
-
Cancer Gene Therapy Market Size to hit $19.97 Billion by 2033 | Key Drivers, Trends, Precision Oncology & FDA
30 Oct 2025 07:32 GMT
… combination therapy of adagrasib and cetuximab for KRAS G12C-mutated colorectal … , Others)
By Application: (Brain Cancer, Lung Cancer, Breast Cancer, Pancreatic Cancer, Liver …
-
Personalizing Lung Cancer Treatment Reduces Toxicity and Improves Cure Rates
08 May 2025 14:25 GMT
… population.3
New lung cancer treatment options have … NSCLC. Chemotherapy-free lung cancer treatment would be … effective.
Advancing Personalized Lung Cancer Treatment
Chemotherapy can cause … cetuximab for unresectable stage III non-small-cell lung cancer. …
-
NANOBIOTIX Announces Presentation of Data From Two Phase 1 Studies Evaluating JNJ-1900 (NBTXR3) at the European Lung Cancer Conference
20 Mar 2025 20:15 GMT
… NBTXR3) for patients with lung cancer (NSCLC) to be … presented at the 2025 European Lung Cancer Conference (“ELCC”). ABSTRACT … Locoregional Recurrent Non-Small Cell Lung Cancer (“NSCLC”)
Saumil J. … therapy, with or without cetuximab, for the treatment …
About
© 1995-2025